<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04109586</url>
  </required_header>
  <id_info>
    <org_study_id>REK 2017/2443</org_study_id>
    <nct_id>NCT04109586</nct_id>
  </id_info>
  <brief_title>Diet and Fat Mass After Traumatic Spinal Cord Injury</brief_title>
  <official_title>Preventing Neurogenic Obesity Following Traumatic Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnaas Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sunnaas Rehabilitation Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized clinical controlled trial (RCT) to investigate the impact of a&#xD;
      personalized nutritional intervention on functional and clinical outcomes the first year&#xD;
      after traumatic spinal cord injury. The long term goal is to prevent gain of body fat mass&#xD;
      and obesity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oral glucose tolerance test (OGTT)</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Standardized oral glucose tolerance test: intake of 75 grams glucose in a fasted state, blood glucose levels measured 2 hours post test (mmol/Liter)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Measuring body weight in kilograms (kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Independency in activities of daily living (ADLs)</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Spinal Cord Independence Measure (SCIM) III will be used to assess various activities of daily living (ADLs). SCIM III comprises 19 items divided into 3 subscales (self-care, respiration and sphincter management, and mobility). The total SCIM score range from 0 to 100, with the subscales weighted as follows: self-care: scored 0-20; respiration and sphincter management: scored 0-40; and mobility: scored 0-40. Scores are higher in patients that require less assistance or fewer aids to complete basic ADLs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in adipose tissue</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Magnetic resonance imaging (MRI) scanning will be used to determine body composition by quantification of adipose tissues (visceral adipose tissue volume and abdominal subcutaneous adipose tissue volume) and muscle volumes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total body water</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Bioimpedance Analysis (BIA) will be used to determine body composition by measuring total body water (TBW).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Quality of life (QoL)</measure>
    <time_frame>Changes from Baseline to 12 months follow-up</time_frame>
    <description>International Spinal Cord Society QoL Basic Dataset. The QoL data set consists of 3 variables: ratings of satisfaction with general quality of life, satisfaction with physical health, and satisfaction with psychological health. All variables are rated on a Numeric Self-Rating Scale ranging from 0 (completely dissatisfied) to 10 (completely satisfied).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in albumin</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of albumin g/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting glucose</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of fasting glucose (mmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Creatinine</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of creatinine umol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lipoprotein A1</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of Lipoprotein A1 (g/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Lipoprotein B</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of Lipoprotein B (g/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in folic acid</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of folic acid (nmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in vitamin B12</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of vitamin B12 pmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Ferritin</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of ferritin ug/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in C-reactive protein (CRP)</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of C-reactive protein mg/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cholesterol</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of total cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL) mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Triglycerides</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of triglycerides mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in C-peptid</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Blood analysis of insulin c-peptid pmol/L in a fasted state and 2 hours post oral glucose tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in vitamin 25-hydroxy-vitamin D₃</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of 25-hydroxy-vitamin D₃ (nmol/L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Glycated hemoglobin (HbA1c)</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of HbA1c mmol/mol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Cytokines: Interleukin-6 and -1, Tumor necrosis factor-α (TNF-α)</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Fasted blood analysis of Interleukin-6 and -1 Tumor necrosis factor-α (TNF-α) (pg/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in isoprostanes (biomarkers of oxidative stress)</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Urine analyses of isoprostanes (ng/mg) (biomarkers of oxidative stress)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiorespiratory fitness levels</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Cardiorespiratory fitness levels will be determined by measuring peak oxygen uptake (VO2peak; ml/kg/min) during maximal exercise testing on a treadmill or ergometry cycle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiorespiratory fitness levels</measure>
    <time_frame>Change from Baseline to 12 months follow-up</time_frame>
    <description>Cardiorespiratory fitness levels will be determined by measuring peak oxygen uptake (VO2peak; liter/min) during maximal exercise testing on a treadmill or ergometry cycle.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Obesity</condition>
  <condition>Metabolic Disease</condition>
  <condition>Spinal Cord Injuries</condition>
  <arm_group>
    <arm_group_label>Personalized nutrition therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietitian led assessment and individual nutritional therapy during inpatient rehabilitation with follow-up the first year after injury</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard treatment</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment includes dietitian-led group session on nutrition after SCI and patient visits / consultations on request from doctor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Personalized nutritional therapy</intervention_name>
    <description>Dietitian led assessment and individual nutritional therapy during inpatient rehabilitation with follow-up the first year after injury</description>
    <arm_group_label>Personalized nutrition therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Traumatic spinal cord injury&#xD;
&#xD;
          -  Levels C1-L2&#xD;
&#xD;
          -  American Spinal Injury Association (ASIA) Impairments Scale (AIS) A-D&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Glasgow Coma Scale score (GCS) equal to or lower than 13&#xD;
&#xD;
          -  Below 18 years of age&#xD;
&#xD;
          -  Medical issues like impaired cognitive function, progressive disorders and&#xD;
             co-morbidities.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vegard Strøm, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnaas Rehabilitation Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanne B Slettahjell, MSc</last_name>
    <phone>004748107330</phone>
    <email>hannebjorg.slettahjell@sunnaas.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Henriksen, Ass.Prof</last_name>
    <phone>004799003128</phone>
    <email>Christine.henriksen@medisin.uio.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sunnaas Rehabilitation Hospital</name>
      <address>
        <city>Nesoddtangen</city>
        <state>Bjørnemyr</state>
        <zip>1453</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanne Bjørg Slettahjell, MSc</last_name>
      <phone>004748107330</phone>
      <email>Hannebjorg.slettahjell@sunnaas.no</email>
    </contact>
    <contact_backup>
      <last_name>Vegard Strøm, PhD</last_name>
      <phone>004790632891</phone>
      <email>vegard.strom@sunnaas.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnaas Rehabilitation Hospital</investigator_affiliation>
    <investigator_full_name>Vegard Strøm</investigator_full_name>
    <investigator_title>Head of Research Group</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

